GSK forges ahead with its dynamic COPD and asthma portfolio

For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.

New hires at Crescendo, Healx and Galecto

In that role, he led the development of Symbicort, a leading respiratory brand.

AZ reports growth again in Q3, driven by oncology and China sales

AZ’s respiratory franchise also grew 18% to $1.3bn – although the company saw a 4% decline in sales of Symbicort, this was offset by the growth of Pulmicort and Fasenra,

AZ builds case for its COPD triple as it chases GSK’s Trelegy

reduction versus older drug Symbicort (formoterol fumarate/budesonide).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]